Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
US Army
Dow
Express Scripts
Cantor Fitzgerald
McKesson
Chinese Patent Office
Merck

Generated: April 26, 2018

DrugPatentWatch Database Preview

SORIATANE Drug Profile

« Back to Dashboard

When do Soriatane patents expire, and what generic alternatives are available?

Soriatane is a drug marketed by Stiefel Labs Inc and is included in one NDA.

The generic ingredient in SORIATANE is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.
Drug patent expirations by year for SORIATANE
Pharmacology for SORIATANE
Ingredient-typeRetinoids
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for SORIATANE
Synonyms for SORIATANE
(2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
(all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(E)-9-(4-METHOXY-2,3,6-TRIMETHYLPHENYL)-3,7-DIMETHYL-2,4,6,8-NONATETRAENOIC ACID
079A839
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-, (all-E)-
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
54757-46-9
55079-83-9
69427-46-9
9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
A830475
AB0007949
AB00698376_09
AB00698376-08
AB07538
AB2000068
ABP000589
AC-4702
AC1NR4LJ
AC1Q5T6I
Acitretin
Acitretin (USAN/INN)
Acitretin (USP/INN)
Acitretin [USAN:INN:BAN]
Acitretin [USAN:USP:INN:BAN]
Acitretin, >=98.0% (HPLC)
Acitretin, British Pharmacopoeia (BP) Reference Standard
Acitretin, European Pharmacopoeia (EP) Reference Standard
Acitretin, pharmaceutical secondary standard; traceable to USP, PhEur
Acitretin, United States Pharmacopeia (USP) Reference Standard
Acitretin/
Acitretina
Acitretina [Spanish]
Acitretine
Acitretine [French]
acitretinoin
Acitretinum
Acitretinum [Latin]
AKOS015889991
all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid
all-trans-Acitretin
all-trans-Etretin
AN-6715
AS-12644
BC209054
BCP9000229
BCPP000437
BDBM50088429
BIDD:GT0617
Bio-0002
BRD-K90699611-001-01-4
CAS-55079-83-9
CCG-220668
CCRIS 5534
CHEBI:50172
CHEBI:50173
CHEMBL1131
CPD000499573
CS-1855
D02754
D05QDC
DB00459
DR001494
DSSTox_CID_2553
DSSTox_GSID_22553
DSSTox_RID_76624
DTXSID6022553
EINECS 259-474-4
Etretin
FT-0082892
GTPL7598
HMS2234L17
HMS3259J12
HSDB 7187
HY-B0107
IHUNBGSDBOWDMA-AQFIFDHZSA-N
Isoacitretin
Isoetretin
KS-5246
LCH760E9T7
LP092636
LS-96920
MLS001076667
MolPort-003-925-892
MolPort-009-120-239
NC00723
NCGC00163127-01
NCGC00163127-02
NCGC00163127-03
Neotigason
Retinoid etretin
Ro 10-1670
Ro 10-1670/000
Ro 13-7652
Ro-10-1670
Ro-10-1670/000
Ro-101670000
Ro-13-7652
RP17661
s1368
SAM002589973
SBB064171
SC-17293
SCHEMBL3759
SMR000499573
Soriatane (TN)
Soriatane CK
Soriatane, Acitretin
Spectrum5_002065
SR-01000763200
SR-01000763200-3
TMMP
Tox21_112012
U0279
UNII-LCH760E9T7
ZINC3798734

US Patents and Regulatory Information for SORIATANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stiefel Labs Inc SORIATANE acitretin CAPSULE;ORAL 019821-001 Oct 28, 1996 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Stiefel Labs Inc SORIATANE acitretin CAPSULE;ORAL 019821-002 Oct 28, 1996 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Stiefel Labs Inc SORIATANE acitretin CAPSULE;ORAL 019821-003 Aug 6, 2009 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Stiefel Labs Inc SORIATANE acitretin CAPSULE;ORAL 019821-004 Aug 6, 2009 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Fish and Richardson
Moodys
Johnson and Johnson
Merck
Covington
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.